NCT03422107

Brief Summary

PNI (Peripheral Nerve Injury) occurs in 5-15% of patients in cardiac surgery. So far, the mechanism of injury has never been researched. In this study, we will compare minimally invasive cardiac surgery with conventional cardiac surgery using a novel portable SSEP device to pinpoint the mechanism and timing of PNI during cardiac surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 20, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 29, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 5, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2018

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2019

Completed
Last Updated

March 12, 2018

Status Verified

January 1, 2018

Enrollment Period

1.1 years

First QC Date

January 29, 2018

Last Update Submit

March 8, 2018

Conditions

Keywords

Peripheral Nerve InjuriesThoracic SurgeryMinimally invasive cardiac surgery

Outcome Measures

Primary Outcomes (1)

  • Cumulative duration of abnormal SSEP

    Defined as the amplitude reduction \>50% from baseline, Latency\>10% from baseline

    From the beginning of the surgery to the end of surgery

Secondary Outcomes (2)

  • The incidence of postoperative peripheral neuropathy at post-operative day 2-5

    Post operative day 2 to 5

  • The number of SSEP abnormal alarms

    From the beginning of the surgery to the end of surgery

Study Arms (4)

TAVI

Transcatheter Aortic Valve Implantation

cAVR

Conventional Valve Replacement

rCABG

minimally invasive coronary artery bypass graft

cCABG

Conventional Coronary Artery Bypass Graft

Eligibility Criteria

Age18 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Our inclusion criteria are all adult (age\>18 years of age) cardiac surgical patients who are undergoing the four following procedures, open AVR, TAVI, conventional CABG, robotic CABG. This 4 groups of patients represent 4 different combination of potential surgical insults- median sternotomy, Internal thoracic artery (ITA) retraction, ITA harvesting, cardiopulmonary bypass and positioning

You may qualify if:

  • ●all adult (age\>18, \<95 years of age) cardiac surgical patients who are undergoing the four following procedures, open AVR, TAVI, conventional CABG, robotic CABG

You may not qualify if:

  • any patients with contraindication to SSEP monitoring, which include skin burns or trauma at SSEP electrode sites
  • lack of written consent
  • emergency surgery
  • language barrier
  • fluctuating neurological signs/symptoms
  • regional anesthesia (spinal, epidural, nerve block)
  • CABG with radial artery harvest, combined cardiac surgeries

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

London Health Sciences Centre

London, Ontario, N6A 5A5, Canada

RECRUITING

MeSH Terms

Conditions

Peripheral Nerve Injuries

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Study Officials

  • John Murkin, MD

    Western University

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 29, 2018

First Posted

February 5, 2018

Study Start

November 20, 2017

Primary Completion

December 31, 2018

Study Completion

June 30, 2019

Last Updated

March 12, 2018

Record last verified: 2018-01

Locations